# Preventing Tolerance to Oxymetazoline in Allergic Rhinitis

> **NCT00846326** · PHASE4 · WITHDRAWN · sponsor: **Brian J Lipworth**

## Conditions studied

- Allergic Rhinitis
- Tachyphylaxis
- Rhinitis Medicamentosa

## Interventions

- **DRUG:** oxymetazoline-fluticasone propionate
- **DRUG:** Oxymetazoline

## Key facts

- **NCT ID:** NCT00846326
- **Lead sponsor:** Brian J Lipworth
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The suppliers were unable to provide the investigational medicinal product (IMP)
- **Last updated:** 2016-10-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00846326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00846326, "Preventing Tolerance to Oxymetazoline in Allergic Rhinitis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00846326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*